From: Evaluation of Ertapenem use with Impact Assessment on Extended-Spectrum Beta-Lactamases (ESBL) Production and Gram-Negative resistance in Singapore General Hospital (SGH)
Adverse drug reaction
No. of Patients (%)
Seizures
9 (1.0)
Seizures occurring in those with previous history of epilepsy
4 (0.4)
Central nervous system side effects (excluding seizures)
20 (2.2)
Gastrointestinal side effects
3 (0.3)
Others*
10 (1.1)